title: Improved biological efficacy of prasugrel one month after an acute coronary syndrome.
authors.forename: Marc
authors.initials: M
authors.lastname: Laine
authors.forename: Mouhamadou Nazirou
authors.initials: MN
authors.lastname: Doddo Siddo
authors.forename: Franck
authors.initials: F
authors.lastname: Paganelli
authors.forename: Françoise
authors.initials: F
authors.lastname: Dignat-George
authors.forename: Laurent
authors.initials: L
authors.lastname: Bonello
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D011446:Prospective Studies; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride